GLP-1 Drugs May Boost Male Fertility, New Study Finds
GLP-1 medications may carry an unexpected benefit for men struggling with weight-related fertility problems.
A new analysis presented Monday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, found that GLP-1 drugs do not harm male reproductive hormones.
In several trials, the medications appeared to improve them.
What The New GLP-1 Fertility Study Found
Researchers from University Hospitals Coventry and Warwickshire and Warwick Medical School in England reviewed randomized controlled trials testing GLP-1 drugs against placebo or other treatments in men aged 18 to 65.
Two independent reviewers screened the literature to limit bias.
The Endocrine Society confirmed that five clinical trials met the eligibility criteria.
📰 Related: GLP-1 Drugs: The Promises and the Troubling Side Effects Nobody Told You About
The strongest signal came from a 24-week semaglutide trial, which showed improved sperm shape and cholesterol readings while testosterone held steady.
A separate 16-week liraglutide study went further, recording measurable testosterone increases in men with obesity-related low testosterone.
Lead Researcher Says Findings Support Treating The Root Cause
Dr. Pratibha Natesh, a consultant endocrinologist at University Hospitals Coventry and Warwickshire and honorary lecturer at Warwick Medical School, led the review.
According to CNN, men in the trials saw improved testosterone, sperm count, and sperm shape after 24 weeks of GLP-1 treatment.
Natesh said the results support shifting away from testosterone replacement therapy in men with obesity-linked low testosterone.
Treating the underlying weight and metabolic issues directly may restore hormone levels on its own.
That distinction carries weight in clinical settings, where testosterone replacement has long been the default response to low readings.
📰 Related: Ozempic Users Are Moving Less, Not More — New Fitbit Study Finds
Why Testosterone Replacement Has Been A Tradeoff For Fertility
Testosterone replacement therapy can lower sperm production by suppressing the body's own hormone signaling — a difficult tradeoff for men hoping to conceive.
Yahoo Health reported that Natesh pointed to two possible mechanisms behind the findings.
Weight loss itself can improve hormone function, and the drugs may also ease inflammation and metabolic stress that limit sperm production.
About 15% of couples in the United States have trouble conceiving, and more than half of those cases involve a male infertility factor, according to Yale Medicine figures cited in the same reporting.
📰 Related: The New Diabetes Pill That Burns Fat Without Ozempic's Side Effects
Outside Researchers Urge Caution Before Drawing Conclusions
Not every expert is ready to call GLP-1 drugs a fertility treatment.
Dr. Lidia Mínguez Alarcón, a reproductive epidemiologist at Brigham and Women's Hospital and Harvard Medical School, told CNN more research is needed before GLP-1s are recommended for male infertility.
She also noted the trials only included men with high body mass index, leaving it unclear whether men without obesity would see similar benefits.
Nature reported that a separate analysis of more than 1,600 men prescribed obesity drugs found testosterone rose by roughly 30% after treatment.
What Happens Next For GLP-1 And Male Fertility Research
Natesh and her co-authors are not claiming GLP-1 drugs should replace fertility treatment.
The evidence base remains small, built from five trials with varying designs.
Larger studies will need to track sperm parameters and live birth outcomes before guidelines shift.
For now, the findings give men already taking GLP-1 drugs for weight loss or diabetes one more factor to weigh with their doctors.
If future trials confirm the pattern, it could reshape how clinicians treat low testosterone in men with obesity — shifting the conversation toward metabolic health rather than hormone replacement.
Key Takeaways
- A new review presented at ENDO 2026 found GLP-1 drugs did not harm male fertility markers.
- A 24-week semaglutide trial showed improved sperm shape and stable testosterone.
- A 16-week liraglutide trial showed testosterone increases in men with obesity-related low testosterone.
- Lead researcher Dr. Pratibha Natesh said findings support treating obesity directly over testosterone replacement.
- Harvard's Dr. Lidia Mínguez Alarcón cautioned the trials only studied men with high BMI.
- About 15% of US couples face infertility, with male factors involved in over half of cases.
Sources
Also Read
Health & Lifestyle Editor
Emma Rhodes covers public health, wellness, medical breakthroughs, and lifestyle trends. She is committed to reporting health news that is accurate, clear, and actionable.
